Mark Lappe insider trades

Open-market stock purchases and sales by Mark Lappe, Chief Executive Officer at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Dec 28, 2020.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -4%.

Recent trades

DateStockTradeValue
Sep 28, 2026INBX Inhibrx Biosciences, IncBought$148K
Sep 28, 2026INBX Inhibrx Biosciences, IncBought$305K
Sep 25, 2026INBX Inhibrx Biosciences, IncBought$329K
Sep 25, 2026INBX Inhibrx Biosciences, IncBought$217K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$585K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$665K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$118K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$54.1K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$136K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$1.1M

Companies traded

  • INBX Inhibrx Biosciences, Inc: 21 buys, 17 sales, last Sep 28, 2026
  • INXB Inhibrx Biosciences, Inc: other filings, last May 30, 2024

Get free alerts when Mark Lappe files a new trade →